# FDA recall D-1487-2020

> **Vilvet Pharmaceuticals Inc.** · Class II · drug recall initiated 2020-07-24.

## Product

VILAMIT MB (118 mg methenamine, 36 mg phenyl salicylate, 40.8 mg sodium phosphate monobasic, 10.0 mg methylene blue and 0.12 mg hyoscyamine sulfate), Rx Only, 100 Capsules per Bottle, Manufactured for: Vilvet Pharmaceuticals Inc., Chester Springs, PA 18425, NDC 71186-002-35.

## Reason for recall

cGMP deviations

## Distribution

Nationwide within the US

## Key facts

- **Recall number:** D-1487-2020
- **Recalling firm:** Vilvet Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-07-24
- **Report date:** 2020-08-12
- **Termination date:** 2022-01-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Chester Springs, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1487-2020

## Citation

> AI Analytics. FDA recall D-1487-2020. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1487-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*